Ritonavir Completed Phase 2 / 3 Trials for Novel Coronavirus Infectious Disease (COVID-19) / Pneumonia / COVID Treatment

IndicationsStatusPurposePhase
CompletedTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs
NCT04343768An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial